Correlation Between Crispr Therapeutics and Twist Bioscience

Can any of the company-specific risk be diversified away by investing in both Crispr Therapeutics and Twist Bioscience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Crispr Therapeutics and Twist Bioscience into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Crispr Therapeutics AG and Twist Bioscience Corp, you can compare the effects of market volatilities on Crispr Therapeutics and Twist Bioscience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Crispr Therapeutics with a short position of Twist Bioscience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Crispr Therapeutics and Twist Bioscience.

Diversification Opportunities for Crispr Therapeutics and Twist Bioscience

0.58

Correlation Coefficient

Crispr Therapeutics  Twist Bioscience

Very weak diversification

The 3 months correlation between Crispr and Twist is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding Crispr Therapeutics AG and Twist Bioscience Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Twist Bioscience Corp and Crispr Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Crispr Therapeutics AG are associated (or correlated) with Twist Bioscience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Twist Bioscience Corp has no effect on the direction of Crispr Therapeutics i.e., Crispr Therapeutics and Twist Bioscience go up and down completely randomly.

Pair Corralation between Crispr Therapeutics and Twist Bioscience

Given the investment horizon of 90 days Crispr Therapeutics is expected to generate 7.14 times less return on investment than Twist Bioscience. But when comparing it to its historical volatility, Crispr Therapeutics AG is 1.22 times less risky than Twist Bioscience. It trades about 0.03 of its potential returns per unit of risk. Twist Bioscience Corp is currently generating about 0.2 of returns per unit of risk over similar time horizon. If you would invest  4,205  in Twist Bioscience Corp on September 4, 2024 and sell it today you would earn a total of  825.00  from holding Twist Bioscience Corp or generate 19.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Crispr Therapeutics AG  vs.  Twist Bioscience Corp

Crispr Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Crispr Therapeutics AG are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating basic indicators, Crispr Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

Twist Bioscience Corp

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Twist Bioscience Corp are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Twist Bioscience unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Crispr Therapeutics and Twist Bioscience

The main advantage of trading using opposite Crispr Therapeutics and Twist Bioscience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Crispr Therapeutics position performs unexpectedly, Twist Bioscience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Twist Bioscience will offset losses from the drop in Twist Bioscience's long position.

The idea behind Crispr Therapeutics AG and Twist Bioscience Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.